Scribd
Upload
16 views7 pages

Drug Emty Page

The document contains instructions for a drug test assessment with questions about oral glucose powder/gel, nitrous oxide and oxygen (Entonox), activated charcoal, and oxygen. It lists descriptions, pharmacological actions, adverse effects, indications, contraindications, precautions, packaging, and dosage/administration for each drug. The test has 62 marks and must be completed within 62 minutes.

Uploaded by

syrieangel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
16 views7 pages

Drug Emty Page

The document contains instructions for a drug test assessment with questions about oral glucose powder/gel, nitrous oxide and oxygen (Entonox), activated charcoal, and oxygen. It lists descriptions, pharmacological actions, adverse effects, indications, contraindications, precautions, packaging, and dosage/administration for each drug. The test has 62 marks and must be completed within 62 minutes.

Uploaded by

syrieangel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 7

AEA 01/2014

DRUG TEST 01

INSTRUCTIONS
1. Read the questions thoroughly
2. Answer all the questions on the answer sheet provided
3. Write neatly and legibly ensuring that your answers are clearly numbered.
4. Any attempt at examination fraud will result in immediate disqualification from the
assessment process.
PAGES: 6 (Including cover)
MARKS 62 Marks
TIME: 62 Minutes

NUMBER OF PAGES: 13 including


cover page and answer sheets MARKS: Marks
PASS MARK: 50%

1
AEA 01/2014
DRUG TEST 01

NAME:__________________________________________________________

DATE: __________________________________________________________

ORAL GLUCOSE POWDER/ GEL

1. DESCRIPTION (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PHARMACOLOGICAL ACTION (1)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

ADVERSE EFFECTS (1)

_____________________________________________________________________
_____________________________________________________________________
____________

INDICATIONS (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

CONTRA-INDICATIONS (2)

_____________________________________________________________________
_____________________________________________________________________
____________

PRECAUTIONS (2)

_____________________________________________________________________
_____________________________________________________________________

2
AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
__________________

DOSAGE AND ADMINISTRATION (3)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
________________________

2. NITROUS OXIDE and OXYGEN (ENTONOX®)

DESCRIPTION (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PHARMACOLOGICAL ACTION (6)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
________________________________________________

PHARMACO-KINETICS (4)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
______________________________

ADVERSE EFFECTS (3)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

3
AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
______________________

INDICATIONS (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________________________________

CONTRA-INDICATIONS (8)

• _______________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

• _________________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
______________________________

• ___________________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PRECAUTIONS (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

4
AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________________________________________________________

PACKAGING (1)

_____________________________________________________________________
_____________________________________________________________________
____________

DOSAGE AND ADMINISTRATION (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_______________
3. ACTIVATED CHARCOAL

DESCRIPTION (2)

• Classification: _______________________________________________________
• Schedule: ____________________________________________________________

PHARMACOLOGICAL ACTION (1)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

5
AEA 01/2014
DRUG TEST 01

4. OXYGEN

PRECAUTIONS (7)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
_______________________________________________________

6
AEA 01/2014
DRUG TEST 01

You might also like